Skip to content

Clinical trials

Phase 1/2 Waldenstrom Macroglobulinemia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 1/2 Country / region: France Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines1
Loxo Oncology, Inc.1
University Hospital, Lille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Follicular2
Lymphoma, Mantle-Cell2
Lymphoma, Non-Hodgkin2
Dendritic Cell Sarcoma, Interdigitating1
Lymphoma, B-Cell1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.